CellWell record HH-377590
Purified EPA versus combined EPA/DHA in coronary heart disease: clinical outcomes, mechanisms, safety, and functional food perspectives
Kylie Yen; Isabella Baghdasaryan; D. Martirosyan
Bioactive Compounds in Health and Disease ยท 2026
In plain language
This narrative review concluded that purified EPA reduced cardiovascular events in selected statin-treated high-risk patients, whereas combined EPA/DHA lowered triglycerides similarly but showed less consistent event reduction.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-377590
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.